These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20706575)

  • 1. Insights in 17beta-HSD1 enzyme kinetics and ligand binding by dynamic motion investigation.
    Negri M; Recanatini M; Hartmann RW
    PLoS One; 2010 Aug; 5(8):e12026. PubMed ID: 20706575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational investigation of the binding mode of bis(hydroxylphenyl)arenes in 17β-HSD1: molecular dynamics simulations, MM-PBSA free energy calculations, and molecular electrostatic potential maps.
    Negri M; Recanatini M; Hartmann RW
    J Comput Aided Mol Des; 2011 Sep; 25(9):795-811. PubMed ID: 21822722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of human 17β-hydroxysteroid dehydrogenase type 1 complexed with estrone and NADP
    Li T; Stephen P; Zhu DW; Shi R; Lin SX
    FEBS J; 2019 Jun; 286(11):2155-2166. PubMed ID: 30768851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the substrate inhibition of human 17β-hydroxysteroid dehydrogenase type 1.
    Li T; Song X; Stephen P; Yin H; Lin SX
    J Steroid Biochem Mol Biol; 2023 Apr; 228():106246. PubMed ID: 36634828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of steroids binding to 17 beta-hydroxysteroid dehydrogenase type 1 using Monte Carlo energy minimization reveals alternative binding modes.
    Blanchet J; Lin SX; Zhorov BS
    Biochemistry; 2005 May; 44(19):7218-27. PubMed ID: 15882060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3D QSAR model of 17beta-HSD1 inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core applying molecular dynamics simulations and ligand-protein docking.
    Karkola S; Lilienkampf A; Wähälä K
    ChemMedChem; 2008 Mar; 3(3):461-72. PubMed ID: 18224704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate inhibition of 17β-HSD1 in living cells and regulation of 17β-HSD7 by 17β-HSD1 knockdown.
    Han H; Thériault JF; Chen G; Lin SX
    J Steroid Biochem Mol Biol; 2017 Sep; 172():36-45. PubMed ID: 28554725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+.
    Sawicki MW; Erman M; Puranen T; Vihko P; Ghosh D
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):840-5. PubMed ID: 9927655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors.
    Breton R; Housset D; Mazza C; Fontecilla-Camps JC
    Structure; 1996 Aug; 4(8):905-15. PubMed ID: 8805577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.
    Gangloff A; Garneau A; Huang YW; Yang F; Lin SX
    Biochem J; 2001 May; 356(Pt 1):269-76. PubMed ID: 11336660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for species specific inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1): computational study and biological validation.
    Klein T; Henn C; Negri M; Frotscher M
    PLoS One; 2011; 6(8):e22990. PubMed ID: 21857977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two non-reactive ternary complexes of estrogenic 17beta-hydroxysteroid dehydrogenase: crystallization and preliminary structural analysis.
    Qiu W; Zhu DW; Azzi A; Campbell RL; Qi H; Poirier D; Lin SX
    J Steroid Biochem Mol Biol; 1999 Mar; 68(5-6):239-44. PubMed ID: 10416839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-based NMR spectra demonstrate an additional phytoestrogen binding site for 17beta-hydroxysteroid dehydrogenase type 1.
    Michiels PJ; Ludwig C; Stephan M; Fischer C; Möller G; Messinger J; van Dongen M; Thole H; Adamski J; Günther UL
    J Steroid Biochem Mol Biol; 2009 Nov; 117(4-5):93-8. PubMed ID: 19631742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH.
    Jin JZ; Lin SX
    Biochem Biophys Res Commun; 1999 Jun; 259(2):489-93. PubMed ID: 10362535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy.
    Mazumdar M; Fournier D; Zhu DW; Cadot C; Poirier D; Lin SX
    Biochem J; 2009 Dec; 424(3):357-66. PubMed ID: 19929851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid dehydrogenase.
    Mazza C; Breton R; Housset D; Fontecilla-Camps JC
    J Biol Chem; 1998 Apr; 273(14):8145-52. PubMed ID: 9525918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-structure of human estrogenic 17beta-HSD1: binding with various steroids.
    Lin SX; Han Q; Azzi A; Zhu DW; Gangloff A; Campbell RL
    J Steroid Biochem Mol Biol; 1999; 69(1-6):425-9. PubMed ID: 10419021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid substitution of arginine 80 in 17beta-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics.
    McKeever BM; Hawkins BK; Geissler WM; Wu L; Sheridan RP; Mosley RT; Andersson S
    Biochim Biophys Acta; 2002 Nov; 1601(1):29-37. PubMed ID: 12429500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico analysis of potential inhibitors for breast cancer targeting 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) catalyses.
    Islam MR; Tayyeb JZ; Paul HK; Islam MN; Oduselu GO; Bayıl I; Abdellattif MH; Al-Ahmary KM; Al-Mhyawi SR; Zaki MEA
    J Cell Mol Med; 2024 Aug; 28(15):e18584. PubMed ID: 39135338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the origins of 17β-hydroxysteroid dehydrogenase type 1 inhibitory activity via QSAR and molecular docking.
    Srungboonmee K; Songtawee N; Monnor T; Prachayasittikul V; Nantasenamat C
    Eur J Med Chem; 2015; 96():231-7. PubMed ID: 25884113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.